|
Post by Cowgirl on Apr 22, 2017 16:41:59 GMT -5
You crack me up. Have you ever posted anything that is positive or remotely optimistic? Not that I can remember. CCI, I agree re Cowgirl and the tenor of her posts; however, I have to agree with her that Deerfield converting debt to equity in this situation is not a positive sign. Sorry. Just lost a lot of money and when people are hanging onto "Commercials, RLS, Matt or Mike speaking at a conference, Damon Dash (who is he?) int'l partnership etc. that's nuts. Remember last fall after Sanofi debt forgiveness/payment and someone on the board was posting "Greatest call ever!". Come on...were 75% lower from that time. It takes sales and it that requires time and a well funded marketing machine. We have neither. Where is the money coming from for a $20 Million dollar ad campaign? So...I'm a frustrated long and just being real. It blows my mind that 70 reps and even more diabetic educators along with all of us management spreading positive discussions with family and friends who have diabetes , that we can't get more then 150 new scripts in a nation w/ 1.5 million T1D's and 20 million T2d's. They need a large pharma to take this on and attack.
|
|
|
Post by akemp3000 on Apr 22, 2017 17:09:10 GMT -5
A few more thoughts. No one really knows what is about to happen except MNKD and Deerfield unless there's a third party. Some can guess gloom and doom, that there's nothing positive going on, there's little cash and the end is near. This is understandable based on the pps and what is known publicly. This perspective makes it quite easy to attack management and the company but may turn out to be based on insufficient information. Others like myself, choose to believe something significant is going on behind the scenes and may be the reason MNKD management doesn't feel the need to defend or respond publicly. This perspective is more difficult to defend because it's based on a belief in management and information that isn't public.
Some are saying an evaluation scenario can't be correct because it would require clinical trial results versus anecdotal evidence. The open market is not the FDA. There are no rules stating what a company needs to consider before making an investment. In the biotech and IT worlds, many giant company's, i.e. Google and Microsoft, have invested Billions of dollars in small companies that own industry changing technologies that have not yet achieved market success. They conduct due diligence and invest based on the belief that they can be successful with the new technology in the market.
I'm not predicting anything but remain hopeful. I do enjoy this MB and hearing all the various perspectives and guesses. As Slugworth said, "we'll find out pretty damn soon now".
|
|
|
Post by lennymnkd on Apr 22, 2017 17:14:34 GMT -5
akemp / in my humbleness, my sentiments exactly.. well said !
|
|
|
Post by gamblerjag on Apr 22, 2017 17:34:40 GMT -5
On April 1st, Mnkd would run out of cash this July. How will Mnkd plan to raise cash without diluting shareholders? As Matt stated on 3/16/17, subsequent to the settlement with Sanofi, our cash balance didn't require an immediate need for funding. We are, obviously, continuing discussions with our current noteholders and other financing opportunities we have been approached with. Matt continues to focus on non-dilutive opportunities, if possible. Deerfield deal followed. Ponder this for a moment. $10M is still due this July. Mnkd hasn't announced how to finance or pay cash for it. In addition, Mnkd needs to extend the runway by 6 additional months to Jan 2018 to see DTC effect and prove commercial viability before big BPs get involve. That's $70 M funding Mnkd needs. Draw your own conclusion. Read more: mnkd.proboards.com/thread/6408/mnkd-state-union?page=19#ixzz4f0r51KZThey Lakers I prefer to hear your opinion rather than posting mine LOL you're much more knowledgeable what do you thinks going to happen by July 1 thanks gambler
|
|
|
Post by sportsrancho on Apr 22, 2017 17:48:16 GMT -5
CCI, I agree re Cowgirl and the tenor of her posts; however, I have to agree with her that Deerfield converting debt to equity in this situation is not a positive sign. Sorry. Just lost a lot of money and when people are hanging onto "Commercials, RLS, Matt or Mike speaking at a conference, Damon Dash (who is he?) int'l partnership etc. that's nuts. Remember last fall after Sanofi debt forgiveness/payment and someone on the board was posting "Greatest call ever!". Come on...were 75% lower from that time. It takes sales and it that requires time and a well funded marketing machine. We have neither. Where is the money coming from for a $20 Million dollar ad campaign? So...I'm a frustrated long and just being real. It blows my mind that 70 reps and even more diabetic educators along with all of us management spreading positive discussions with family and friends who have diabetes , that we can't get more then 150 new scripts in a nation w/ 1.5 million T1D's and 20 million T2d's. They need a large pharma to take this on and attack. Cowgirl, just to add another thing that is weird. It seems like there are at least 100 people on Afrezza in CA alone! What is going on in the other states?
|
|
|
Post by silentknight on Apr 22, 2017 19:13:28 GMT -5
On April 1st, Mnkd would run out of cash this July. How will Mnkd plan to raise cash without diluting shareholders? As Matt stated on 3/16/17, subsequent to the settlement with Sanofi, our cash balance didn't require an immediate need for funding. We are, obviously, continuing discussions with our current noteholders and other financing opportunities we have been approached with. Matt continues to focus on non-dilutive opportunities, if possible. Deerfield deal followed. Ponder this for a moment. $10M is still due this July. Mnkd hasn't announced how to finance or pay cash for it. In addition, Mnkd needs to extend the runway by 6 additional months to Jan 2018 to see DTC effect and prove commercial viability before big BPs get involve. That's $70 M funding Mnkd needs. Draw your own conclusion. Read more: mnkd.proboards.com/thread/6408/mnkd-state-union?page=19#ixzz4f0r51KZTQuite frankly, Matt's done nothing but double talk lately. He says one thing and then does another. Folks want Matt to say or do something to support the share price. Honestly, I don't. Every time he tries he only embarrasses himself and the company further. I'd rather they say nothing at all than continually try to convince shareholders and investors that they're in a good position. They aren't and that's clear to see. He may be focusing on non-dilutive opportunities, but the Deerfield deal WAS dilutive. MNKD doesn't have leverage with any existing lender or debt holder, or with any new potential debt holders to come up with a deal that isn't on bad terms. What could MNKD possibly sell as a positive to a financeer today to provide them encouragement to lend them millions of dollars on good terms? I can't think of any. Dwindling cash reserves, poor sales, additional debt due this year and next, with arguably no way to pay for it. As someone pointed out earlier, their only likely sources of cash are further dilution (good luck raising more than a few million dollars with the share price in the toilet AGAIN) or getting into bed with a vulture hedge fund even worse than Deerfield which will likely require significant concessions that will once again destroy shareholders. I understand folks want to remain optimistic since there's nothing left, but I look at things and I just don't see what could possibly be there to be optimistic about. Look at the share price. The market doesn't either.
|
|
|
Post by falconquest on Apr 22, 2017 20:53:53 GMT -5
Ok, let's put things into a real perspective here. When you look at the totality of Mannkind as an investment over 10 plus years what is the conclusion you come to? I rest my case.
|
|
|
Post by slugworth008 on Apr 22, 2017 21:23:42 GMT -5
We'll DB well find out pretty damn soon now won't we. If they pull another rabbit out of their hat I'll look forward to your comments in that. If they pull a rabbit out of a hat, I shall gladly eat crow and sing the praises of Matt. Though first I will likely run around my neighborhood doing the happy dance... www.youtube.com/watch?v=iFNLbAs3KAUYou can dance if you want to ----
|
|
|
Post by sportsrancho on Apr 22, 2017 22:11:27 GMT -5
Ok, let's put things into a real perspective here. When you look at the totality of Mannkind as an investment over 10 plus years what is the conclusion you come to? I rest my case. That MNKD is the way I lose money. I had a system, I would buy 4 stocks after I did some DD and thought they had the most up side and they were going to move soon. I'd set a 12% trailing stop. If I got stopped out I was wrong and I would move my money to the other 3 stocks. As they moved up I would add. ( Kinda like Nicolas Darvas ) I only went by the tape. I might glance at the news but I wouldn't read it. No message boards. I'd end up with one or two that made me bank. This would go on until the last stock stopped moving. Then I'd sell and start over with 4 more. With bio's I'd buy during the run up to approval and sell before the news. So when I saw MNKD was 8 months from its 3rd go around I told Tom, " we have to go in BIG here. It's going to run from 1.89 to 8+ bucks in 8 months. Then we sell. Look at the 10 year chart and what's it's done before!" He said, I'm in! The more he read about Afrezza the more hooked he got. We didn't sell:-) Being the dad of two T1's he decided to try and get them in the trials. You guys know the rest of the story. No trials...off -label script. Success! Kids picked up the dosing in no time. Freedom! No more ER lows in the middle of the night. Family life changed forever! We bought more stock! There is no doubt in Tom's mind that Afrezza IS for everyone! The doctors just don't know how to teach dosing. ( You need a MNKD long to do that! ) That's how you lose millions in the market. And yes he too bought more last week:-)
|
|
|
Post by akemp3000 on Apr 22, 2017 22:16:25 GMT -5
Ok, let's put things into a real perspective here. When you look at the totality of Mannkind as an investment over 10 plus years what is the conclusion you come to? I rest my case. This puts history in perspective. That's fine but has no correlation to the future which remains unknown.
|
|
|
Post by sweedee79 on Apr 23, 2017 14:27:35 GMT -5
The relatively recent graph showing a significant increase in sample packs distributed by the new sales team. Even though scripts have remained flat, the pps is in the tank and MNKD management is saying nothing, it is possible we are finally about to see scripts move up. If scripts continue to remain flat, it would mean that ALL diabetic recipients of these sample packs chose to disregard Afrezza which, based on user feedback, is highly unlikely. Additionally, there's a reason MNKD management is moving forward with commercials, supporting the upcoming reality series and has filed a notice regarding its management team and a potential change in ownership. Add to this Deerfield's decision to convert debt to equity and all together these signs foreshadow something. Wish we knew what. One of many possible scenarios is that MNKD is approaching the end of a lengthy evaluation period where some BP wanted confirmation of real world efficacy without problems before finalizing a deal to take it and run with it. I am as frustrated as anyone but remain convinced another chapter in this long running saga is about to unfold that won't be titled seven or eleven. I am out... but I haven't lost hope and am still in full support of this company and looking for a reason to get back in..... I have lost over 30K on my investment to date...I held 50K shares,. my cost average was 1.25 per share.. and I sold at .58 presplit ...
I totally believe in Afrezza and cant believe we are where we are with such a remarkable product... I am also angry that things turned out this way.. I don't entirely blame management but rather our healthcare system .. how many other great products get blackballed the way this one did. It seems to me its all about greed and what is acceptable according to our standard of care... or those who are too scared to change and risk their own neck...
Management was put in a tough position when SNY bailed... it takes a lot of cash to market a product ... any product, much less one that changes the standard of care... Ive known this for a while.. Saw it with my own eyes... But I still hope that some miracle will happen.. so as not to lose the best innovation in the treatment of diabetes since insulin treatment was discovered... I don't care about the so called artificial pancreas.... it doesn't hold a candle to something as natural and as easy as Afrezza..... the only thing that would is a cure..
Best wishes to the company... and all who need Afrezza ...
|
|
|
Post by lennymnkd on Apr 23, 2017 15:41:25 GMT -5
Look what I'm about to say I realize is far from sofisicated ! BUT , I would be a hell of a lot more concerned if 90% of diabetic's knew about AFREZZA and we were in the position we are in .. but with only 10% aware of what's available to them , and even them getting aclamated to understanding the science and proper usage makes for a great deal of consideration that we are at the levels we are at / just think about ! With the CGM and a onslot of my pillow ad's .. being facetious !!!! Somewhat / we can't help to win , Like Al Mann said , all it take is MONEY / Some cash rich outfit has to see what some of us see . They invest thier money and resources and some of the most rediculous idear's ... this seems blue chip in comparison to most investments ..
|
|
|
Post by dreamboatcruise on Apr 23, 2017 15:52:12 GMT -5
On April 1st, Mnkd would run out of cash this July. How will Mnkd plan to raise cash without diluting shareholders? As Matt stated on 3/16/17, subsequent to the settlement with Sanofi, our cash balance didn't require an immediate need for funding. We are, obviously, continuing discussions with our current noteholders and other financing opportunities we have been approached with. Matt continues to focus on non-dilutive opportunities, if possible.Deerfield deal followed. Ponder this for a moment. $10M is still due this July. Mnkd hasn't announced how to finance or pay cash for it. In addition, Mnkd needs to extend the runway by 6 additional months to Jan 2018 to see DTC effect and prove commercial viability before big BPs get involve. That's $70 M funding Mnkd needs. Draw your own conclusion. Read more: mnkd.proboards.com/thread/6408/mnkd-state-union?page=19#ixzz4f0r51KZTBased on the dilution of the Deerfield conversion, I guess we can conclude that non-dilutive opportunities are indeed NOT possible.
|
|
|
Post by nadathing on Apr 23, 2017 16:43:55 GMT -5
...just hope they are not just cutting their loses with the stock and have a real game plan in our interest . The best way to evaluate any lender is to research the other deals they have done and see how they have behaved in similar circumstances. All investors (venture capital, private equity, hedge funds, etc.) all put some fluff text on their web pages about how they structure deals in the interest of the company to make it a win-win situation with both sides sharing the upside. Don't believe it for a second; institutional investors are in it for the bucks because their managers are compensated on total fund return, and anything that lowers total return is anathema to a fund manager. Go ahead and look at the Deerfield deals that have gone sideways, and there have been plenty of those, and see how they have behaved. If you think they have a game plan other than minimizing their loss then I think you will be disappointed. Small town banks will bend over backwards to support a local business that runs into trouble, partly because they are answerable to the community they serve; Deerfield is a multi-billion dollar hedge fund answerable to their investors. Calibrate your expectations accordingly. My guess is they cut their loss and sold. Others took notice and did the same.
|
|
|
Post by lakers on Apr 23, 2017 20:44:31 GMT -5
On April 1st, Mnkd would run out of cash this July. How will Mnkd plan to raise cash without diluting shareholders? As Matt stated on 3/16/17, subsequent to the settlement with Sanofi, our cash balance didn't require an immediate need for funding. We are, obviously, continuing discussions with our current noteholders and other financing opportunities we have been approached with. Matt continues to focus on non-dilutive opportunities, if possible.Deerfield deal followed. Ponder this for a moment. $10M is still due this July. Mnkd hasn't announced how to finance or pay cash for it. In addition, Mnkd needs to extend the runway by 6 additional months to Jan 2018 to see DTC effect and prove commercial viability before big BPs get involve. That's $70 M funding Mnkd needs. Draw your own conclusion. Read more: mnkd.proboards.com/thread/6408/mnkd-state-union?page=19#ixzz4f0r51KZTBased on the dilution of the Deerfield conversion, I guess we can conclude that non-dilutive opportunities are indeed NOT possible. Nice try, dbc. Matt'd better have more than one rabbit. We need $70M by July.
|
|